These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. Srivastava KC, Malhotra N. Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):73-81. PubMed ID: 2011614 [Abstract] [Full Text] [Related]
3. Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves. Srivastava KC, Justesen U. Prostaglandins Leukot Med; 1987 Sep; 29(1):11-8. PubMed ID: 3118394 [Abstract] [Full Text] [Related]
4. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Raghavendra RH, Naidu KA. Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):73-8. PubMed ID: 19501497 [Abstract] [Full Text] [Related]
5. Extract of a spice--omum (Trachyspermum ammi)-shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Srivastava KC. Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):1-6. PubMed ID: 3141935 [Abstract] [Full Text] [Related]
6. Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. Chen SJ, Wang MH, Chen IJ. Gen Pharmacol; 1996 Jun; 27(4):629-33. PubMed ID: 8853295 [Abstract] [Full Text] [Related]
7. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Srivastava KC, Bordia A, Verma SK. Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):223-7. PubMed ID: 7784468 [Abstract] [Full Text] [Related]
8. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Aharony D, Smith JB, Silver MJ. Biochim Biophys Acta; 1982 Oct 08; 718(2):193-200. PubMed ID: 6814496 [Abstract] [Full Text] [Related]
9. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol. Lin CH, Kuo YH, Lin YL, Teng CM. J Pharm Pharmacol; 1994 Jan 08; 46(1):54-7. PubMed ID: 8201527 [Abstract] [Full Text] [Related]
10. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C. Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038 [Abstract] [Full Text] [Related]
11. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Chang MC, Uang BJ, Tsai CY, Wu HL, Lin BR, Lee CS, Chen YJ, Chang CH, Tsai YL, Kao CJ, Jeng JH. Br J Pharmacol; 2007 Sep 19; 152(1):73-82. PubMed ID: 17641677 [Abstract] [Full Text] [Related]
12. The effect of acetylsalicylate on aggregation and arachidonate metabolism by human platelets suspended in plasma or buffer. McDonald-Gibson WJ, McDonald-Gibson RG, Power GM, Collier HO. Prostaglandins Leukot Med; 1984 Jul 19; 15(1):1-14. PubMed ID: 6433360 [Abstract] [Full Text] [Related]
13. Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid. Takenaga M, Hirai A, Terano T, Tamura Y, Kitagawa H, Yoshida S. Thromb Res; 1986 Feb 01; 41(3):373-84. PubMed ID: 3010490 [Abstract] [Full Text] [Related]
14. In vitro effect of trichosanic acid, a major component of Trichosanthes japonica on platelet aggregation and arachidonic acid metabolism in human platelets. Takenaga M, Hirai A, Terano T, Tamura Y, Kitagawa H, Yoshida S. Prostaglandins Leukot Essent Fatty Acids; 1988 Feb 01; 31(2):65-72. PubMed ID: 3357911 [Abstract] [Full Text] [Related]
15. Aspirin inhibits platelet 12-hydroxy-eicosatetraenoic acid formation. Eynard AR, Galli G, Tremoli E, Maderna P, Magni F, Paoletti R. J Lab Clin Med; 1986 Jan 01; 107(1):73-8. PubMed ID: 3941295 [Abstract] [Full Text] [Related]
16. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S, Westwick J, Kakkar VV. Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666 [Abstract] [Full Text] [Related]
17. Relative effects of flurbiprofen on platelet 12-hydroxy-eicosatetraenoic acid and thromboxane A2 production: influence on collagen-induced platelet aggregation and adhesion. Van Ryan-McKenna J, Buchanan MR. Prostaglandins Leukot Essent Fatty Acids; 1989 Jun 01; 36(3):171-4. PubMed ID: 2780761 [Abstract] [Full Text] [Related]
18. Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate. Buchanan MR, Butt RW, Hirsh J, Markham BA, Nazir DJ. Prostaglandins Leukot Med; 1986 Feb 01; 21(2):157-68. PubMed ID: 3083434 [Abstract] [Full Text] [Related]
19. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
20. Evidence for the mechanism by which garlic inhibits platelet aggregation. Srivastava KC. Prostaglandins Leukot Med; 1986 Jun 01; 22(3):313-21. PubMed ID: 3088604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]